The growing diabetes epidemic: Why we need to care about the burden of T2D
Beta-cell dysfunction, insulin resistance, and insufficient GLP-1 activity in T2D
Evaluating research: The role of endogenous GLP-1
Insufficient GLP-1 activity in T2D
Should we be thinking about diabetes differently?